Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M731Revenue (TTM) $M69.9Net Margin (%)15.6Altman Z-Score6.8
Enterprise Value $M633EPS (TTM) $0.2Operating Margin %15.0Piotroski F-Score6
P/E(ttm)65.3Beneish M-Score16.5Pre-tax Margin (%)15.3Higher ROA y-yY
Price/Book6.610-y EBITDA Growth Rate %--Quick Ratio7.7Cash flow > EarningsY
Price/Sales10.55-y EBITDA Growth Rate %--Current Ratio7.7Lower Leverage y-yY
Price/Free Cash Flow55.5y-y EBITDA Growth Rate %--ROA % (ttm)8.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)12.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M70.1ROIC % (ttm)85.2Gross Margin Increase y-yN

Gurus Latest Trades with PGNX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PGNX is held by these investors:



PGNX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Broadfin Healthcare Master Fun10% Owner 2017-02-15Sell602,600$9.668.07view
Broadfin Healthcare Master Fun10% Owner 2017-02-09Sell351,300$9.717.52view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-06-11Sell2,000$6.8352.86view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-13Sell3,000$749.14view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-11Sell2,000$6.8352.86view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-03-03Sell5,000$6.4960.86view
ISRAEL ROBERT JExecutive Vice President, Medi 2015-01-12Sell2,000$7.0647.88view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-12-11Sell3,000$7.0747.67view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-21Sell9,000$749.14view
ISRAEL ROBERT JExecutive Vice President, Medi 2014-11-13Sell10,000$6.8352.86view

Quarterly/Annual Reports about PGNX:

News about PGNX:

Articles On GuruFocus.com
Tiger Management’s Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, Monsanto, Nov 14 2014 
Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street Nov 07 2014 
Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX Jan 27 2013 
Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX Oct 01 2012 
5 Stocks That Dropped the Most Since Gurus Bought Them Sep 13 2012 
Dendreon Could Push Higher If New Drug Trials Succeed Apr 23 2012 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Dec 01 2010 
Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Nov 02 2010 
Progenics Pharmaceuticals Inc. (PGNX) CEO Paul J Maddon buys 5,000 Shares Oct 04 2010 

More From Other Websites
Biotech Premarket Movers: Progenics, Alexion, BioCryst Feb 16 2017
Progenics Pharmaceuticals and Shutterfly to Join S&P SmallCap 600 Feb 15 2017
Progenics Pharmaceuticals Announces Initiation of a Phase 1 Clinical Trial of its PSMA-Targeted... Feb 14 2017
Progenics Pharmaceuticals, Inc. to Participate in February Investor Conferences Feb 08 2017
Progenics Pharm upgraded by Needham Feb 06 2017
Progenics Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PGNX) : January 30, 2017 Jan 30 2017
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change... Jan 30 2017
Progenics Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PGNX-US :... Jan 27 2017
ETFs with exposure to Progenics Pharmaceuticals, Inc. : January 20, 2017 Jan 20 2017
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jan 09 2017
My Top 2017 Pick: Progenics Pharmaceuticals Jan 03 2017
Progenics shares rally as prostate cancer imaging study to continue Dec 22 2016
Progenics Pharmaceuticals Announces Independent Committee's Positive Recommendation for Continuation... Dec 22 2016
Progenics Pharmaceuticals Announces Independent Committee’s Positive Recommendation for... Dec 22 2016
ETFs with exposure to Progenics Pharmaceuticals, Inc. : December 12, 2016 Dec 12 2016
Is Progenics Pharmaceuticals, Inc. (PGNX) a Good Stock to Buy? Dec 09 2016
Progenics Pharmaceuticals Announces First Patient Dosed in Phase 2/3 Clinical Trial of PSMA-Targeted... Dec 07 2016
Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor Nov 30 2016
ETFs with exposure to Progenics Pharmaceuticals, Inc. : November 23, 2016 Nov 23 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)